Introduction
============

Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, skin changes (POEMS) syndrome is a rare systemic disease associated with underlying plasma cell dyscrasia. Although its pathogenesis is not yet fully understood, its clinical manifestations have been attributed to increased concentrations of serum or plasma vascular endothelial growth factor (VEGF).^[@B1]^ Although a diagnosis of POEMS syndrome can be suspected based on the clinical course, the infrequency of this disease has often resulted in diagnostic and therapeutic delay.^[@B2]^ No single test is sufficient to establish a diagnosis of POEMS syndrome. In addition, even with the previously established diagnostic criteria,^[@B1]^ there have been reports of patients not satisfying the criteria but for whom a therapeutic strategy also taking into consideration the possibility of POEMS syndrome is needed.^[@B2]^ In contrast, other cases have been described that despite satisfying these criteria continue to show a clinically benign course inconsistent with POEMS syndrome.^[@B3]^ The existence of such cases suggests that the recent criteria may be inappropriate in some situations but too strict in others to identify patients that require specific treatment for POEMS syndrome.

Therefore, there is a need for an examination that is easy to perform and that can reveal abnormalities specific to POEMS syndrome. The clinical manifestations of POEMS syndrome are thought to be associated with microangiopathy, neovascularization, and accelerated vasopermeability. Tissue vascular permeability is considered to increase in parallel with serum VEGF level. Therefore, VEGF released from plasma cells and/or platelets may induce edema and microangiopathy/macroangiopathy, potentially resulting in the various clinical features of POEMS syndrome. POEMS syndrome can be associated with cerebral infarction as a result of cerebral vasculopathy.^[@B4],[@B5]^ Although contrast-enhanced cranial magnetic resonance imaging (MRI) of POEMS syndrome has revealed a high frequency of pachymeningeal enhancement,^[@B6],[@B7]^ to our knowledge, there have been no previous studies using pre- and post-contrast fluid-attenuated inversion recovery (FLAIR) in the evaluation of pachymeningeal involvement of POEMS syndrome. This suggested that contrast-enhanced cranial MRI using both FLAIR and T~1~-weighted images (T~1~WI) may contribute to accurate and more specific evaluation of pachymeningeal involvement in POEMS syndrome.

In this study, we evaluated the distribution and imaging manifestations of cranial pachymeningeal involvement in POEMS syndrome using both pre- and post-contrast FLAIR and T~1~WI.

Materials and Methods
=====================

This study was approved by the local institutional review board, and informed consent was obtained from each patient for MRI examination using contrast medium. We encountered nine cases of POEMS syndrome diagnosed according to the clinical criteria of Dispenzieri.^[@B8]^ We performed cranial MRI to evaluate ischemic brain damage in POEMS syndrome. In addition, we also performed contrast-enhanced MRI using both pre- and post-contrast FLAIR and T~1~WI to evaluate pachymeningeal involvement.

Clinical and laboratory data of the nine cases of POEMS syndrome are listed in [Table 1](#T1){ref-type="table"}. Most clinical and laboratory examinations were performed before the MRI examination, but cerebrospinal fluid (CSF) examination was performed after cranial MRI. In our institution, the normal serum VEGF level is \< 38 pg/ml, the normal CSF protein concentration range is 10--40 mg/dl, and the normal CSF pressure range is 50--150 mmH~2~O.

MRI was performed using a 1.5T imager in seven cases and 3.0T imager in two cases (both Signa; GE Medical Systems, Milwaukee, WI). FLAIR imaging was performed using a fast FLAIR sequence with a repetition time/effective echo time/inversion time of 10000/175/2200 ms on 1.5T MRI and 9000/150/2400 ms on 3.0T MRI. T~1~WI was performed using the 2-dimensional spin echo (SE) method (TR, TE: 500, 8) in both 1.5T and 3.0T MRI examinations. We did not use a fat suppression technique. All of the imaging sequences were acquired with a slice thickness/interslice gap = 5/1 mm. In our institution, the routine MRI protocol for meningeal diseases includes both axial and coronal pre- and post-contrast FLAIR and T~1~WI, including diffusion-weighted, sagittal T~1~WI, and axial T~2~-weighted images. We adopted this protocol to evaluate the pachymeningeal involvement of POEMS syndrome. Post-contrast images were obtained after slow intravenous administration (manual injection) of 0.1 mmol/kg body weight gadopentetate dimeglumine (Gd-DTPA; Magnevist, Bayer Healthcare Pharmaceutical, Berlin, Germany, or Gd-DTPA- bismethylamide (Gd \[DTPA-BMA\]); Omniscan Daiichi-Seiyaku, Tokyo, Japan). Post-contrast FLAIR imaging was performed before post-contrast T~1~WI in all MRI examinations.

Three neuroradiologists (O.M., H.A., and Y.Y.) each with \> 10 years of experience who were unaware of the diagnosis of POEMS syndrome reviewed all of the pre- and post-contrast MR images. The pachymeningeal thickness was evaluated using pre-contrast FLAIR and classified as normal or abnormal. Assessments of the degree and extent of the contrast enhancement effect using a pair of pre- and post-contrast FLAIR and T~1~WI were performed. Pre- and post-contrast images were compared side by side to determine the degree of enhancement effect. The degree of contrast enhancement effect in all cases was evaluated by all of the reviewers and recorded independently in each of three separate anatomical regions, i.e., falx cerebri, cerebral convexity, and tentorium cerebelli. After independent review, a consensus was reached regarding the results.

On post-contrast FLAIR, the normal dural sinus is occasionally enhanced,^[@B9]^ but the normal pachymeninges and cortical vessels are usually not enhanced; therefore, we determined the degree of enhancement as "not detected," "positive" (i.e., detectable), or "prominent." In addition, the degrees of contrast enhancement of the pachymeninges were graded as "normal," "positive," or "prominent" on post-contrast T~1~WI. As normal pachymeninges show segmental enhancement on post-contrast T~1~WI,^[@B10],[@B11]^ we determined the degree of contrast enhancement based on accumulated past experience of normal range enhancement of post-contrast T~1~WI in our institution. Positive enhancement was determined as "more conspicuous" or "continuous enhancement" on T~1~WI evaluated by viewing several adjacent slices images and determined based on the consensus of all three reviewers. Prominent enhancement was determined as definitely continuous thick pachymeningeal enhancement on each post-contrast-FLAIR or T~1~WI.

Results
=======

The results of the consensus regarding the range of pachymeningeal thickness of pre-contrast FLAIR and degree of post-contrast enhancement of FLAIR and T~1~WI of the pachymeninges by the three reviewers are shown in [Tables 2](#T2){ref-type="table"}--[4](#T4){ref-type="table"}. The detectability of abnormalities in each examination of different anatomical parts and summary data are shown in [Table 5](#T5){ref-type="table"}. Pre-contrast FLAIR showed 41% (11/27) abnormal regions. Although post-contrast T~1~WI showed enhancement in all examinations in all regions, 48% (13/27) of MRI examinations were judged to show a normal range in each of the regions ([Fig. 1](#F1){ref-type="fig"}). Post-contrast FLAIR did not detect any contrast enhancement on 26% (7/27) of the regions, but showed positive enhancement on 30% (8/27) and prominent enhancement on 44% (12/27) ([Figs. 2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}). Post-contrast T~1~WI showed prominent enhancement on 41% (11/27) ([Fig. 3](#F3){ref-type="fig"}), and positive enhancement on 11% (3/27) of the regions. Post-contrast T~1~WI did not show prominent enhancement on the regions where post-contrast FLAIR did not reveal any enhancement. Detectability of pachymeningeal abnormality was highest in post-contrast FLAIR74% (20/27).

Discussion
==========

Pachymeningeal involvement is an abnormality associated with POEMS syndrome that has already been discussed from the viewpoints of both imaging and histopathological features, with the former showing prominent enhancement and the latter showing hyperplasia of meningothelial cells, neovascularization, and obstructive vessel remodeling, without inflammation.^[@B6]^ POEMS syndrome has also been noted to manifest arterial and venous thrombosis that may result in cerebral infarction, and so some reports have attributed the MRI findings of POEMS syndrome to the vascular insults of intracranial vessel involvement.^[@B4],[@B12]^ The performance of contrast-enhanced cranial MRI after routine brain examination can provide additional information in cases of probable POEMS syndrome. We consider there to be two aspects to the clinical impact of pachymeningeal involvement of POEMS syndrome revealed as prominent enhancement, the first being to help improve the diagnostic accuracy and the second to assess the therapeutic results in follow-up, because successful chemotherapy may be reflected by a reduction in the degree of pachymeningeal enhancement corresponding with that in the serum VEGF level, which is an index representing disease severity.^[@B7]^

With regard to pachymeningeal contrast enhancement on MRI, normal pachymeninges are highly vascularized but do not usually show enhancement on post-contrast FLAIR. However, in practice post-contrast FLAIR images showed more conspicuous linear pachymeningeal enhancement around the operation site than on post-contrast T~1~WI.^[@B9]^

Proliferation of meningothelial cells, narrowing or occlusion of arterioles, thickening of the media and endothelial hyperplasia, and neovascularization with prominent capillary endothelial cells within loose extracellular matrix were reported as characteristics of cranial pachymeningeal involvement in POEMS syndrome.^[@B6]^ Another ultrastructural study indicated opening of endothelial cell tight junctions in POEMS syndrome patients and suggested that alteration of microvascular hyperpermeability may be induced by VEGF.^[@B13]^ Gd distribution remodeling occurring with opening of endothelial cell tight junctions in the involved pachymeninges may reveal stronger pachymeningeal enhancement on both post-contrast FLAIR and T~1~WI. However, it is difficult to discuss the signal intensity in dural tissue correlated with Gd concentration.

Delayed enhancement of the dura has been reported in even spin-density- and T~2~-weighted images,^[@B14]^ meaning that when we evaluate the contrast enhancement superiority or inferiority between post-contrast FLAIR and post-contrast T~1~WI, it is important to consider image acquisition timing from intravenous injection. We performed post-contrast FLAIR first followed by post-contrast T~1~WI, and so the delayed enhancement effect was not more conspicuous in post-contrast FLAIR than post-contrast T~1~WI.

Although post-contrast T~1~WI usually shows enhancement of the pachymeninges because of the rich vascularity of the dura mater, discrimination between normal and abnormal enhancement is not easy. One reason is that the extent of normal pachymeningeal enhancement has a vague range even on standard post-contrast spin echo (SE) T~1~WI.^[@B10],[@B11],[@B14]^ Another reason is that the imaging appearance of post-contrast T~1~WI depends on the pulse sequence and parameters selected and the magnetic field strength of the machine.^[@B15],[@B16]^ With regard to the contrast enhancement effect when using the same amount of contrast medium, MRI at 3.0T showed greater contrast effects than that using a 1.5T machine.^[@B16]^ Moreover, on comparison of contrast enhancement patterns on 3D gradient-echo and SE images, long segment enhancement of the normal pachymeninges is routinely observed on contrast-enhanced 3D gradient-echo images.^[@B11]^

The elevated VEGF level is thought to be one major causative factor of POEMS syndrome. Neovascular formation may induce prominent thick enhancement of the pachymeninges. Although we do not feel that prominent pachymeningeal enhancement is specific to POEMS syndrome, the thick pachymeningeal enhancement in POEMS syndrome may be related to the opening of tight junction microvasculature induced by VEGF. Therefore, in patients with POEMS syndrome-like symptoms not satisfying the current criteria, determination of a pachymeningeal abnormal enhancement by post-contrast FLAIR may contribute to decision-making on starting appropriate therapy for POEMS syndrome.

Our study had several limitations. First, evaluation of pachymeningeal involvement in POEMS syndrome was performed without pathological confirmation, and therefore the actual correlation between pathology and contrast enhancement effect was not determined. This study was retrospective in nature, and was therefore subject to bias. The sample size allowed descriptive analysis, but was too small for statistical analysis. We did not perform fat-suppressed MRI in T~1~WI, which is considered to be superior to FLAIR for depicting intracranial meningeal diseases,^[@B17]^ and so the pachymeninges on post-contrast T~1~WI may have been more conspicuous if fat suppression had been used. In addition, 3D imaging methods, such as 3D T~2~-FLAIR and 3D gradient-echo T~1~WI, are commonly used in the clinical MRI acquisition. 3D T~2~-FLAIR has high sensitivity to flow,^[@B17]^ and 3D gradient-echo T~1~WI shows normal dural enhancement more prominently than that revealed by SE T~1~WI.^[@B11]^ A correlation study of these two pulse sequences may further develop the discussion.

Conclusions
===========

Pachymeningeal enhancement can be seen on both post-contrast FLAIR and T~1~WI in POEMS syndrome. Although the detectability of contrast enhancement is superior in post-contrast T~1~WI, post-contrast FLAIR may contribute to objective judgment in the evaluation of pachymeningeal involvement in POEMS syndrome.

![Case 4. Coronal pre- and post-contrast FLAIR (**A, B**) and T~1~WI (**C, D**). Pre-contrast FLAIR showed normal range thickness of pachymeninges in both falx and convexity. Post-contrast FLAIR imaging shows positive enhancement of the falx cerebri, where post-contrast T~1~WI showed normal range enhancement (arrows). FLAIR, fluid-attenuated inversion recovery.](mrms-16-231-g1){#F1}

![Case 7. Axial pre- and post-contrast FLAIR (**A, B**) and T~1~WI (**C, D**). Pre-contrast FLAIR showed normal range thickness of pachymeninges in both falx and convexity. Both post-contrast FLAIR and T~1~WI showed prominent enhancement of the falx cerebri (arrows). Post-contrast T~1~WI showed normal range enhancement of the convexity, whereas post-contrast FLAIR showed negative enhancement (small arrows).FLAIR, fluid-attenuated inversion recovery.](mrms-16-231-g2){#F2}

![Case 6. Axial pre- and post-contrast FLAIR (**A, B**) and T~1~WI (**C, D**). Pre-contrast FLAIR revealed thickened pachymeninges (arrows). Both pre-contrast FLAIR and T~1~WI showed prominent enhancement of the pachymeninges of both the falx cerebri and cerebral convexity (arrows). FLAIR, fluid-attenuated inversion recovery.](mrms-16-231-g3){#F3}

###### 

Patients' characteristics and laboratory studies of 9 cases of POEMS syndrome

  **Case**   **Age/Sex**   **Polyneuropathy**   **Organomegaly**   **Endocrinopathy**   **M protein**   **Systemic edema**   **Bone lesions**   **VEGF (pg/ml)**   **CSF protein (mg/dl)**   **CSF pressure (mmH~2~O)**
  ---------- ------------- -------------------- ------------------ -------------------- --------------- -------------------- ------------------ ------------------ ------------------------- ----------------------------
  1          64/M          \+                   \+                 \+                   IgAλ            \+                   Sclerotic          609                105                       150
  2          69/F          \+                   \+                 \+                   IgGλ            \+                   Sclerotic          2000               56                        205
  3          71/M          \+                   \+                 \+                   IgGλ            \+                   Sclerotic          319                115                       150
  4          49/M          \+                   \+                 \+                   IgAλ            \+                   Lytic              1690               65                        200
  5          65/F          \+                   \+                 \+                   IgAλ            \+                   Sclerotic          1400               80                        120
  6          73/F          \+                   \+                 \+                   IgAλ            \+                   Sclerotic          5020               210                       195
  7          56/M          \+                   \+                 \+                   IgAλ            \+                   Sclerotic          6900               150                       170
  8          55/F          \+                   \+                 \+                   IgAλ            \+                   Sclerotic          322                50                        230
  9          57/F          \+                   \+                 \+                   IgAλ            \+                   Sclerotic          1160               101                       140

CSF, cerebrospinal fluid; POEMS, polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, skin changes; VEGF, vascular endothelial growth factor.

###### 

Pachymeningeal thickeness of 9 cases of POEMS syndrome: evaluation by pre-contrast FLAIR

  **Case**   **Age/Sex**   **Magnet**   **Location and degree of contrast enhancement**        
  ---------- ------------- ------------ ------------------------------------------------- ---- ----
  1          64/M          1.5T         \+                                                \+   NR
  2          69/F          1.5T         \+                                                \+   NR
  3          71/M          1.5T         \+                                                \+   NR
  4          49/M          3T           NR                                                NR   NR
  5          65/F          1.5T         \+                                                NR   NR
  6          73/F          3T           \+                                                \+   \+
  7          56/M          1.5T         NR                                                NR   NR
  8          55/F          1.5T         NR                                                NR   \+
  9          57/F          1.5T         NR                                                NR   NR

NR, Normal range; +, Thickening; POEMS, polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, skin changes; FLAIR, fluid-attenuated inversion recovery.

###### 

Degree of pachymeningeal enhancement in 9 cases of POEMS syndrome: evaluation by post-contrast FLAIR

  **Case**   **Age/Sex**   **Magnet**   **Location and degree of contrast enhancement**          
  ---------- ------------- ------------ ------------------------------------------------- ------ ------
  1          64/M          1.5T         \+ +                                              \+ +   ND
  2          69/F          1.5T         \+                                                \+ +   ND
  3          71/M          1.5T         \+ +                                              \+ +   \+
  4          49/M          3T           \+                                                \+     ND
  5          65/F          1.5T         \+ +                                              \+     \+
  6          73/F          3T           \+ +                                              \+ +   \+ +
  7          56/M          1.5T         \+ +                                              ND     ND
  8          55/F          1.5T         \+ +                                              ND     \+ +
  9          57/F          1.5T         \+                                                \+     ND

ND, Not detected; +, Positive enhancement; + +, Prominent enhancement; POEMS, polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, skin changes; FLAIR, fluid-attenuated inversion recovery.

###### 

Degree of pachymeningeal enhancement in 9 cases of POEMS syndrome: evaluation by post-contrast T~1~WI

  **Case**   **Age/Sex**   **Magnet**   **Location and degree of contrast enhancement**          
  ---------- ------------- ------------ ------------------------------------------------- ------ ------
  1          64/M          1.5T         \+ +                                              \+     NR
  2          69/F          1.5T         \+                                                \+ +   NR
  3          71/M          1.5T         \+ +                                              \+ +   NR
  4          49/M          3T           NR                                                NR     NR
  5          65/F          1.5T         \+ +                                              NR     NR
  6          73/F          3T           \+ +                                              \+ +   \+ +
  7          56/M          1.5T         \+ +                                              NR     NR
  8          55/F          1.5T         \+ +                                              NR     \+ +
  9          57/F          1.5T         NR                                                \+     NR

NR, Normal range enhancement; +, Positive enhancement; + +, Prominent enhancement; POEMS, polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, skin changes.

###### 

Detectablility of pachymeningeal abnormality of POEMS syndrome

  **Image modalitiy location**   **Falx cereberi**   **Crebral convexity**   **Tentorium cerebelli**   **Total**
  ------------------------------ ------------------- ----------------------- ------------------------- ------------
  Pre-contrast FLAIR             5/9(56%)            4/9(44%)                2/9(22%)                  11/27(41%)
  Gd-FLAIR                       9/9(100%)           7/9(78%)                4/9(33%)                  20/27(74%)
  Gd-T~1~WI                      7/9(78%)            5/9(56%)                13/9(22%)                 11/27(48%)

POEMS, polyneuropathy, organomegaly, endocr monoclonal gammopathy, skin changes; FLAIR, fluid-attenuated inversion recovery.
